The U.S. Food and Drug Administration (FDA) has approved the use of Pfizer, Inc. (NYSE: PFE) and BioNTech SE’s (NASDAQ: BNTX) COVID-19 vaccine as a booster dose for children aged five to 11 years. The booster shot should be administered at least five months after taking the primary doses of the vaccine, the FDA said. Peter Marks, the Director of the FDA's Center for Biologics Evaluation and Research, said, “The Pfizer-BioNTech COVID-19 vaccine is effective in helping to prevent the most severe consequences of COVID-19 in individuals five years of age and older.
https://www.tipranks.com/news/pfizers-covid-19-vaccine-bags-fda-nod-again?utm_source=advfn.com&utm_medium=referral
Pfizer (NYSE:PFE)
過去 株価チャート
から 6 2022 まで 7 2022 Pfizerのチャートをもっと見るにはこちらをクリック
Pfizer (NYSE:PFE)
過去 株価チャート
から 7 2021 まで 7 2022 Pfizerのチャートをもっと見るにはこちらをクリック